Sjoukje I. Lok

Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

Dirk J. Lok, Sjoukje I. Lok, Pieta W. Bruggink‐André de la Porte et al. · Clinical Research in Cardiology · 2012 · 214 citations · Full text

Medicine, Cardiology, Physiology +13

Circulating Growth Differentiation Factor-15 Correlates with Myocardial Fibrosis in Patients with Non-Ischaemic Dilated Cardiomyopathy and Decreases Rapidly After Left Ventricular Assist Device Support

Sjoukje I. Lok, Björn Winkens, Roel Goldschmeding et al. · European Journal of Heart Failure · 2012 · 150 citations · Full text

Medicine, Cardiology, Internal Medicine +7

A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart

Stefanos Leptidis, Hamid el Azzouzi, Sjoukje I. Lok et al. · PLoS ONE · 2013 · 100 citations · Full text

Medicine, Cardiology, Physiology +15

Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure

Dirk J. Lok, IJsbrand T. Klip, Sjoukje I. Lok et al. · The American Journal of Cardiology · 2013 · 96 citations · Full text

Medicine, Cardiology, Clinical Cardiology +12

Stanniocalcin 2: Characterization of the Protein and its Localization to Human Pancreatic Alpha Cells

Emma Moore, Rolf Kuestner, Darrell Conklin et al. · Hormone and Metabolic Research · 1999 · 67 citations

Life Sciences, Biochemistry, Molecular Biology +5